Moderna's combination COVID-19/influenza shot demonstrated superior immune responses compared to individual vaccines, utilizing a streamlined approach with lower doses and potentially extended shelf life.
In a study with over 8,000 adults, the combo vaccine produced significantly higher antibody levels against influenza and COVID-19 variants, with the older group showing 64% higher antibodies against the XBB.1.5 variant.
[
Collection
]
[
|
...
]